Uncategorized

CDMO Project Management: The Definitive Playbook for Pharma IP Teams, R&D Leads, and Institutional Investors

Pharma IP teams don’t lose value because they lack patents. They lose value because the work that creates the patentable “proof” is mismanaged.
That’s the uncomfortable truth behind many CDMO engagements: project management isn’t just an operational fu…

CDMO Project Management: The Definitive Playbook for Pharma IP Teams, R&D Leads, and Institutional Investors Read Post »

Uncategorized

Your Drug’s Patent Expired. Now What? The Complete Strategic Guide to Patent Cliffs, Lifecycle Defense, and Post-Exclusivity Competition

Your drug’s patent just expired. Now what?
For pharma leaders, the moment a patent cliff hits can feel like a cliff edge—sudden, unforgiving, and often too late to reverse. But the real story is rarely “expired vs. not expired.” It’s a lifecycle stor…

Your Drug’s Patent Expired. Now What? The Complete Strategic Guide to Patent Cliffs, Lifecycle Defense, and Post-Exclusivity Competition Read Post »

Biotechblog
Scroll to Top